Nov 9 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* To hold conference call for investors to provide business update
* Says conference call on November 10 will consist of an overview of current
plans and priorities
* Says conference call will consist of an overview of the transition plan from
Philidor, and an update on the company's operations
* CEO Pearson (L:PSON), CFO Rosiello, company group chairman Ari Kellen, company group
chairman Deb Jorn, corporate controller Carro to conduct the call
* Source text for Eikon ID:nPn9JP1DY
* Further company coverage VRX.TO